Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Empagliflozin in posttransplantation diabetes mellitus: a prospective, interventional pilot study on glucose metabolism, fluid volume, and patient safety
Chandra Shekhar H, Joshua L, Thomas JV
Our experience across chronic-care categories enables procurement teams to streamline sourcing and reduce operational complexity
Documents to bring: Insurance card and any pre-authorization reference numbers Most recent lab results (within 3 months: fasting glucose, HbA1c, lipid panel, liver enzymes, thyroid function) List of all current medications with dosages Written weight history with dates, methods tried, and outcomes Documentation of any weight-related diagnoses (hypertension, prediabetes, sleep apnea, PCOS, etc.) Printed list of questions (from the section above) Numbers to know: Your current BMI (calculate beforehand) Your highest adult weight and the date Your target weight or goal BMI range Duration of your most recent lifestyle intervention Relevant lab values (A1c, fasting glucose, blood pressure trend) Phrases to remember: "I would like to discuss GLP-1 receptor agonists as part of a comprehensive treatment plan" "My BMI is [number], and I have [comorbidity]
Infusions typically run 2 to 4 hours
US$ 26.68
US$ 25.63
US$ 29.78
